First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models

• Julie A. Kelly
• , Noreen T. Boyle
• , Natalie Cole
• , Gillian R. Slator
• , M. Alessandra Colivicchi
• , Chiara Stefanini
• , Oliviero L. Gobbo
• , Gaia A. Scalabrino
• , Sinead M. Ryan
• , Marwa Elamin
• , Cathal Walsh
• , Alice Vajda
• , Margaret M. Goggin
• , Matthew Campbell
• , Deborah C. Mash
• , Shane M. O'Mara
• , David J. Brayden
• , John J. Callanan
• , Keith F. Tipton
• , Laura Della Corte
• , Jackie Hunter
• , Kathy M. O'Boyle
• , Carvell H. Williams
• , Orla Hardiman